Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Zynex Inc (ZYXI)

Zynex Inc (ZYXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Zynex Financial Restructuring Puts Company on Path to Long-Term Success PR Newswire - Tue Dec 16, 7:00AM CST

ENGLEWOOD, Colo. , Dec. 16, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Zynex Announces Strategic Initiatives: Engagement of Province, Appointment of Paul Aronzon to Board of Directors, and Formation of Special Committee PR Newswire - Fri Nov 14, 7:15AM CST

ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Zynex Sets Third Quarter 2025 Earnings Call PR Newswire - Fri Nov 14, 7:00AM CST

ENGLEWOOD, Colo. , Nov. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Analysts Offer Insights on Healthcare Companies: Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) and Zynex (ZYXI) Tipranks - Fri Oct 17, 4:18AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD – Research Report) and Zynex (ZYXI –...

ZYXI : 0.1250 (-34.90%)
Analysts Offer Insights on Healthcare Companies: Zynex (ZYXI) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) Tipranks - Fri Oct 17, 4:02AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Zynex (ZYXI – Research Report) and Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD –...

ZYXI : 0.1250 (-34.90%)
Zynex Expands Board, Appoints New Director Tipranks - Wed Oct 15, 4:50PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Zynex ( (ZYXI)...

ZYXI : 0.1250 (-34.90%)
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair PR Newswire - Tue Oct 14, 5:07PM CDT

ENGLEWOOD, Colo. , Oct. 14, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for...

ZYXI : 0.1250 (-34.90%)
Zynex Seeks Partner for NiCO CO-Oximeter Commercialization Tipranks - Wed Oct 8, 4:48PM CDT

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Zynex ( (ZYXI)...

ZYXI : 0.1250 (-34.90%)
Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles PR Newswire - Mon Aug 18, 7:15AM CDT

ENGLEWOOD, Colo. , Aug. 18, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 0.1250 (-34.90%)
Zynex Reports Second Quarter 2025 Financial Results PR Newswire - Thu Jul 31, 3:01PM CDT

ENGLEWOOD, Colo. , July 31, 2025 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices...

ZYXI : 0.1250 (-34.90%)

Barchart Exclusives

As Tesla Faces a New Investigation Over Door Safety, How Should You Play TSLA Stock Heading into 2026? Barchart - 12 minutes ago
Tesla faces door-safety scrutiny, high valuation, and mixed demand while eyeing long-term growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot